Toronto, ON-Image-guided steroid injection produces durable clinical improvement in inflamed ankles of children with juvenile idiopathic arthritis and may help prevent irreversible deformity, Dr Kevin ...

Patients with arthritic ankles that were treated nonoperatively with consecutive intra-articular injections of hyaluronic acid experienced symptomatic relief which sometimes lasted for several months.

San Francisco and Santa Rosa, CA - Injections of sodium hyaluronate into the knee joint are FDA-approved and widely used for treatment of knee osteoarthritis (OA). A pilot study reported by Dr Robert ...

Background: The effect on clinical safety of dampening articular mechanoreceptor feedback at the ankle is unknown. Injection of the ankle joint for pain control may result in such dampening. Athletes ...

ORLANDO -- The use of intra-articular corticosteroid injections during ankle arthroscopy was associated with an increased rate of postoperative infections, a researcher reported here. During the 6 ...

VYN201 demonstrated statistically significant improvement in treatment response for both endpoints at 1mg/kg and 10mg/kg doses VYN201 also demonstrated numerically superior results at 1mg/kg and ...

A re-evaluation was undertaken in the Arthritis Clinic of the Philadelphia General Hospital to compare results with those obtained by other investigators. Included in this study are a number of cases ...

Intra-articular injections of corticosteroids for relief of the pain of hip or knee osteoarthritis (OA) may have adverse long-term consequences, researchers suggested. These injections are commonly ...

I manage an outpatient pain center in Munich and have for many years given intra-articular injections of opiates (morphine, hydromorphone) instead of cortisone in patients with osteoarthritis and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Talocrural PRP injections yielded no improvements in ...

BRIDGEWATER, N.J., March 30, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company focused on developing proprietary, innovative, and ...